- Home
- SOPH vs AMRN Comparison
SOPH vs AMRN Comparison
Compare SOPH & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOPH | AMRN |
|---|---|---|
| Founded | 2011 | 1989 |
| Country | Switzerland | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.4M | 339.8M |
| IPO Year | 2021 | 1993 |
Fundamental Metrics
Financial Performance| Metric | SOPH | AMRN |
|---|---|---|
| Price | $4.78 | $13.68 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 99.0K | 84.3K |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $73,297,000.00 | ★ $226,733,000.00 |
| Revenue This Year | $18.32 | N/A |
| Revenue Next Year | $15.61 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.66 | N/A |
| 52 Week Low | $2.58 | $7.08 |
| 52 Week High | $5.30 | $20.90 |
Technical Indicators
Market Signals| Indicator | SOPH | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 53.24 | 31.29 |
| Support Level | $4.60 | $13.41 |
| Resistance Level | $4.95 | $14.30 |
| Average True Range (ATR) | 0.26 | 0.77 |
| MACD | -0.03 | -0.09 |
| Stochastic Oscillator | 32.89 | 8.33 |
Price Performance
Historical ComparisonAbout SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.